Coronavirus - we're here to help
From how to access your account online, scam awareness, your wellbeing and our community we're here to help.

Skip to main content
  • Register
  • Help
  • Contact us
  • Log in to HL Account

Genkyotex (GKTX) EUR1

Sell:€2.63 Buy:€2.76 Change: €0.04 (1.40%)
Market closed |  Prices as at close on 5 March 2021 | Switch to live prices |
Sell:€2.63
Buy:€2.76
Change: €0.04 (1.40%)
Market closed |  Prices as at close on 5 March 2021 | Switch to live prices |
Sell:€2.63
Buy:€2.76
Change: €0.04 (1.40%)
Market closed |  Prices as at close on 5 March 2021 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

GenKyoTex SA, formerly known as Genticel SA, is a France-based company involved in the biotechnology sector. The Company focuses on the development of therapies based on selective inhibition of nicotinamide adenine dinucleotide phosphate oxidase (NOX) enzymes, which cause a range of disease processes, such as fibrosis, inflammation, pain processing, cancer development and neurodegeneration. The Company's pipeline includes GKT831, a NOX inhibitor aimed at primary biliary cholangitis (PBC) and fibrosis; GKT771, a NOX inhibitor mainly aimed at inflammatory pain and angiogenesis, and other NOX inhibitors, which target at central nervous system (CNS), hearing loss and oncology.

Contact details

Address:
516 rue Pierre Et Marie Curie
ST-JULIEN-EN-GENEVOIS
74166
France
Telephone:
+33 (5) 61287060
Website:
https://www.genkyotex.com

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
GKTX
ISIN:
FR0013399474
Market cap:
€38.63 million
Shares in issue:
12.06 million
Sector:
Biotechnology
Exchange:
Euronext Paris
Country:
France
Currency:
Euro
Indices:
n/a

Key personnel

  • Claudio Nessi
    Chairman of the Board
  • Ilias Papatheodorou
    Chief Executive Officer, Director

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.